Table: begin end state 1 19 non-cytoplasmic 20 41 transmembrane 42 52 cytoplasmic 53 73 transmembrane 74 84 non-cytoplasmic 85 113 transmembrane 114 133 cytoplasmic 134 152 transmembrane 153 181 non-cytoplasmic 182 202 transmembrane 203 213 cytoplasmic 214 235 transmembrane 236 254 non-cytoplasmic 255 277 transmembrane 278 335 cytoplasmic 336 354 transmembrane 355 360 non-cytoplasmic 361 385 transmembrane 386 394 cytoplasmic
Input: >WP_090442758.1 NCBI__GCF_900100495.1:WP_090442758.1 MQTTANTSRPRASVWTDPKVRAWLFQILAVIVVVALGWYLFDNTQTNLEKRGIISGFAFL NNSAGFGIAQHLIDYSESDTYGRVFVIGLLNTLLVSVIGIVGATILGFILGVARLSPNWL IGKLATVYIETFRNIPPLLQIFFWYFAVMLSLPGPRQSLEIGQAFFLNSRGLYMPAPSPT EAFVTFVGALVVAIIGAVLVARWSKKRFEATGKLFPVSLGAVPLLLGLPGLAVLLTGNPL QWSTPELTGFNFRGGWVMIPELIALTLALTIYTAAFIAENVRSGILAVSHGQTEAARSLG LPAGKTLRLVIIPQALRVIIPPLTSQYLNLAKNSSLAAGIGYPDMVSLFAGTVLNQTGQA IEVIAITMSVYLAISISISMLMNWYNKRIALIER
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server